About Biovie (BIVI)
BioVie Inc. is a clinical stage biotechnology company engaged in the discovery, development and commercialization of therapies targeting life-threatening complications of liver cirrhosis. The Company's initial disease target is ascites a condition im... Read more
- USD0.91
- USD1.31
- USD0.88
- USD7.50
- 2.60%
- --
- 8.96M
- 144.44k
- 16M
- 0.62
- -82.50%
Stock News
4 hours ago
Why Rigetti Computing, Inc. (RGTI) Went Up On Friday
Yahoo
yesterday
Trump administration asks the Supreme Court to restore ‘DOGE’ access to Social Security data
MarketWatch
yesterday
Here are our biggest winners and losers from Wall Street's stellar week
CNBC
yesterday
Newark flight disruptions pile up as United Airlines blames FAA staffing, technology
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
